Fake Azomix Antibiotic Alert: Health Department Orders Urgent Recall

Urgent Recall of Counterfeit Azomix Antibiotic

The provincial health department has sounded the alarm after laboratory testing revealed that a 500 mg batch of Azomix antibiotic was counterfeit. This discovery has prompted immediate action to safeguard patients and prevent unsafe medicines from circulating in the market.

According to the Drug Testing Laboratory, routine analysis confirmed the batch was fake. In response, the Health Department issued a formal alert, directing the manufacturer to recall the affected stock without delay. Pharmacies and medical outlets have been instructed to remove the counterfeit medicine from their shelves.

Drug inspectors across the province are now actively monitoring pharmacies to ensure the fake batch is no longer being sold. The department emphasized that this step is crucial to protect public health and stop the spread of substandard or harmful medicines.

Officials also confirmed that a deeper investigation is underway to trace how the counterfeit batch entered the supply chain. This will help authorities strengthen safeguards against future incidents of fake pharmaceuticals.

Healthcare providers and pharmacists have been urged to remain vigilant. Any suspected stock of the counterfeit Azomix should be reported immediately to regulatory authorities. This proactive reporting will help prevent patients from being exposed to potentially dangerous medication.

The health department’s swift response highlights the importance of drug safety and regulatory oversight in Pakistan. With counterfeit medicines posing serious risks, the recall of Azomix serves as a reminder for both healthcare professionals and patients to stay alert and prioritize verified, authentic medicines.